华泰联合证券有限责任公司 关于 2025 年度胜科纳米（苏州）股份有限公司及子公司 拟向金融机构申请授信额度及为子公司提供担保额度预计 事项的核查意见 华泰联合证券有限责任公司（以下简称"华泰联合证券"或"保荐人"）作为胜 科纳米（苏州）股份有限公司（以下简称"胜科纳米"或"公司"）首次公开发行股 票并在科创板上市持续督导阶段的保荐人，根据《证券发行上市保荐业务管理办 法》《上海证券交易所科创板股票上市规则》《上海证券交易所科创板上市公司 自律监管指引第 1 号——规范运作》等有关规定，对公司向金融机构申请综合授 信额度及为子公司提供担保额度预计事项进行了审慎尽职调查，具体核查情况如 下： 一、银行授信及担保情况 （一）公司及子公司拟向金融机构申请授信情况 | 胜科纳米（苏州）股份有限公司 | 胜科纳米（南京）有限公司 | | | --- | --- | --- | | | 胜科纳米（福建）有限公司 | 0.21 | | 担保人 | 被担保人 胜科纳米（深圳）有限公司 | 预计担保额度（亿元） 0.44 0.45 | | 担保人 | 被担保人 | 预计担保额度（亿元） | | --- | --- | --- ...

证券代码：688757 证券简称：胜科纳米 公告编号：2025-012 胜科纳米（苏州）股份有限公司 关于董事辞任暨选举公司第二届董事会职工代表董 事的公告 二、关于选举职工代表董事的情况 为保障公司董事会正常运行，根据《中华人民共和国公司法》《上海证券交 易所科创板上市公司自律监管指引第 1 号——规范运作》等法律法规、规范性文 件和《公司章程》等的相关规定，公司于 2025 年 5 月 19 日召开公司 2025 年第 一次职工代表大会。经全体与会职工表决，选举 HUA YOUNAN 先生（简历见附件） 为公司第二届董事会职工代表董事，任期自本次职工代表大会审议通过起至第二 届董事会任期届满为止。 上述职工代表董事符合《中华人民共和国公司法》等法律法规、规范性文件 和《公司章程》等规定的任职条件。董事会中兼任公司高级管理人员以及由职工 代表担任的董事人数总计不超过公司董事总数的二分之一。 特此公告。 胜科纳米（苏州）股份有限公司 董事会 2025 年 5 月 21 日 附件： 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责 ...

Core Viewpoint - The article highlights the growth and innovative business model of Shengke Nano, a leading third-party semiconductor testing laboratory in Suzhou, which has adopted a "Labless" approach to meet the increasing demand for specialized testing services in the semiconductor industry [1][3]. Company Overview - Shengke Nano was established in 2004 in Singapore and became Southeast Asia's largest third-party chip testing laboratory by 2011. The company was founded in Suzhou in 2012 by Li Xiaomin, who identified a growing need for specialized testing as the domestic semiconductor industry advanced [4]. - The company has developed a unique "Labless" business model, similar to the "Fabless" model in semiconductor manufacturing, allowing semiconductor firms to outsource testing and analysis to specialized third-party laboratories [1][3]. Financial Performance - Shengke Nano's revenue has shown significant growth, with figures of approximately 168 million yuan in 2021, 287 million yuan in 2022, and 394 million yuan in 2023. Corresponding net profits were 27.5 million yuan, 65.6 million yuan, and 98.5 million yuan, respectively [2]. - The company currently possesses analysis instruments valued at around 800 million yuan and is actively expanding its production capacity through strategic partnerships with top global analysis instrument suppliers [2]. Market Trends - The "Labless" model is gaining traction in the semiconductor industry, driven by the increasing complexity of semiconductor technology and the rising costs associated with in-house laboratory setups [1][3]. - Shengke Nano aims to replicate the success of TSMC, which took nearly 40 years to become a leader in the chip foundry industry, by leveraging its "Labless" model to enhance the efficiency and performance of semiconductor research and development [3]. Future Outlook - Shengke Nano projects that its revenue for the first quarter of 2025 will reach between 110 million to 120 million yuan, representing a year-on-year growth of 26.78% to 38.31% [2]. - The company is positioned to play a crucial role in the ongoing advancement of the semiconductor industry, particularly as the demand for specialized testing services continues to rise [4].

Group 1: Fund Overview - Chunhou Lijia Mixed A Fund, established on July 29, 2022, has a total management scale of 0.02 billion yuan [1] - The fund aims to create stable returns exceeding the performance benchmark through asset allocation while strictly controlling risks and maintaining liquidity [1] - As of April 25, 2025, the fund achieved a one-year return of 10.25%, outperforming the benchmark growth rate of 4.93% and the CSI Mixed Fund Index return of 6.33% [1] Group 2: Shareholder Structure - The proportion of institutional investors in the fund reached 9.64%, increasing by 9.64 percentage points over six months [1] - Fund employees hold 85.21% of the shares, totaling 855,500 shares [1] Group 3: Industry Insights - The semiconductor industry is experiencing rapid growth, driving a surge in demand for semiconductor testing and analysis [2] - The third-party laboratory testing and analysis market in the semiconductor sector has significant growth potential, with the Labless model gaining industry recognition [2] - Continuous R&D investments, driven by advancements in semiconductor technology, are expected to sustain the growth of third-party testing and analysis demand, particularly in advanced processes [2] Group 4: Company Service and Sales Model - The company employs a production model based on sales, implementing order-based production tailored to customer needs [2] - It focuses on quality and efficiency in testing services, continuously optimizing production processes to enhance service quality [2] - The sales model is direct, allowing the company to provide personalized testing solutions and respond promptly to customer needs [2] Group 5: Competitive Advantages - The company has a technological R&D advantage, with capabilities covering advanced processes up to 3nm, positioning it among industry leaders [2] - It holds a strong market position in the third-party testing and analysis market, with significant revenue scale and market share [2] - The company is recognized as a national-level "little giant" and has established a strong brand effect within the industry [2] - The technical team comprises individuals with experience from top institutions and global semiconductor firms, enhancing the company's technical strength [2] - The company has a unique international advantage with laboratories in both China and Singapore, differentiating it from domestic competitors [2] Group 6: Future Development Plans - The company plans to leverage its technical talent and maintain high R&D investment to capitalize on domestic semiconductor development opportunities [2] - It aims to enhance its analytical capabilities in advanced processes, packaging, high-performance chips, and third-generation semiconductor materials [2] - The company will expand its focus on failure analysis and reliability analysis for automotive-grade chips while exploring new fields like aerospace and biomedicine [2] - It intends to broaden its customer reach through a multi-point domestic layout and standardize laboratory replication to accelerate business expansion [2]

证券代码：688757 证券简称：胜科纳米 公告编号：2025-011 胜科纳米（苏州）股份有限公司 2025年第一次临时股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东大会召开的时间：2025 年 4 月 28 日 （二） 股东大会召开的地点：江苏省苏州市工业园区朝前路 9 号公司会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 102 | | --- | --- | | 普通股股东人数 | 102 | | 2、出席会议的股东所持有的表决权数量 | 255,707,659 | | 普通股股东所持有表决权数量 | 255,707,659 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 63.4020 | | 例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 63.4020 | （ ...

上海市锦天城律师事务所 关于胜科纳米（苏州）股份有限公司 2025 年第一次临时股东大会的 法律意见书 地址：上海市浦东新区银城中路 501 号上海中心大厦 9/11/12 层 电话：021-20511000 传真：021-20511999 邮编：200120 上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 关于胜科纳米（苏州）股份有限公司 2025 年第一次临时股东大会的 法律意见书 致：胜科纳米（苏州）股份有限公司 上海市锦天城律师事务所（以下简称"本所"）接受胜科纳米（苏州）股份有 限公司（以下简称"公司"）委托，就公司召开 2025 年第一次临时股东大会（以 下简称"本次股东大会"）的有关事宜，根据《中华人民共和国公司法》（以下简 称"《公司法》"）、《上市公司股东会规则》等法律、法规、规章和其他规范性 文件以及《胜科纳米（苏州）股份有限公司章程》（以下简称"《公司章程》"） 的有关规定，出具本法律意见书。 为出具本法律意见书，本所及本所律师依据《律师事务所从事证券法律业务 管理办法》和《律师事务所证券法律业务执业规则（试行）》等规定，严格履行 了法定职责，遵循了勤勉尽责和诚实信用原则，对 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688757 证券简称：胜科纳米 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假 记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息的真 实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 ■ (二)非经常性损益项目和金额 √适用 □不适用 单位:元 币种:人民币 ■ 二、股东信息 (一)普通股股东总数和表决权恢复的优先股股东数量及前十名股东持股情况表 单位：股 ■ 持股5%以上股东、前10名股东及前10名无限售流通股股东参与转融通业务出借股份情况 对公司将《公开发行证券的公司信息披露解释性公告第1号一一非经常性损益》未列举的项目认定为非 经常性损益项目且金额重大的，以及将《公开发行证券的公司 ...

证券代码：688757 证券简称：胜科纳米 公告编号：2025-010 胜科纳米（苏州）股份有限公司 关于更换持续督导保荐代表人的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 特此公告。 胜科纳米（苏州）股份有限公司 董事会 2025 年 4 月 25 日 附件：姚泽安个人简历 姚泽安，女，保荐代表人，曾参与胜科纳米科创板 IPO 项目、翔楼新材创 业板 IPO 项目、翔楼新材向特定对象发行股票项目、赛伍技术公开发行可转债 项目，在保荐业务执业过程中严格遵守《证券发行上市保荐业务管理办法》等相 关规定，执业记录良好。 胜科纳米（苏州）股份有限公司（以下简称"公司"）于近日收到保荐机构 华泰联合证券有限责任公司（以下简称"华泰联合"）出具的《华泰联合证券有 限责任公司关于更换胜科纳米（苏州）股份有限公司首次公开发行股票持续督导 保荐代表人的函》。原担任公司首次公开发行股票项目的保荐代表人涂清澄先生 因工作变动不能继续担任持续督导期的保荐工作。根据相关法律法规及监管规定 的要求，为保证持续督导工作的有序进行，由保荐代表 ...

Financial Performance - Revenue for Q1 2025 reached ¥108,548,186.51, an increase of 25.11% compared to ¥86,761,894.58 in the same period last year[4] - Net profit attributable to shareholders was ¥11,519,012.52, reflecting a growth of 34.14% from ¥8,587,040.35 year-on-year[4] - Net profit excluding non-recurring gains and losses increased by 79.44%, amounting to ¥11,315,044.87 compared to ¥6,305,850.32 in the previous year[4] - Basic and diluted earnings per share rose to ¥0.0317, a 33.76% increase from ¥0.0237 in the same period last year[4] - Operating profit for Q1 2025 was ¥12,585,973.44, representing a 30.1% increase from ¥9,650,499.58 in Q1 2024[18] - Other comprehensive income after tax for Q1 2025 was ¥392,072.24, recovering from a loss of ¥212,802.85 in Q1 2024[19] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,801,518,752.17, up 20.74% from ¥1,492,105,289.02 at the end of the previous year[5] - The company's cash and cash equivalents increased significantly to CNY 374,483,196.26 from CNY 112,620,868.69, representing a growth of about 232.5%[13] - Total current liabilities decreased to CNY 269,225,182.70 from CNY 320,153,046.74, a reduction of approximately 15.9%[15] - The accounts receivable increased to CNY 114,239,893.57 from CNY 102,355,285.46, showing a growth of about 11.5%[13] - The company's inventory slightly increased to CNY 23,557,518.02 from CNY 23,189,875.54, reflecting a growth of approximately 1.6%[13] - Long-term borrowings increased to CNY 555,038,486.10 from CNY 502,515,909.26, indicating a rise of about 10.5%[15] - The total liabilities remained stable at CNY 886,219,935.15 compared to CNY 886,139,338.63, showing minimal change[15] Shareholder Information - Shareholders' equity attributable to the parent company increased by 51.05% to ¥915,298,817.02 from ¥605,965,950.39[5] - The number of ordinary shareholders at the end of the reporting period was 15,934[9] - The company completed its initial public offering during the reporting period, contributing to the increase in shareholders' equity[7] - The company has not reported any significant changes in shareholder relationships or actions during the reporting period[12] Cash Flow - The net cash flow from operating activities was ¥39,409,503.89, a slight increase of 3.52% compared to ¥38,070,586.40 in the same period last year[4] - Cash flow from operating activities for Q1 2025 was ¥39,409,503.89, slightly up from ¥38,070,586.40 in Q1 2024[23] - The company reported a net cash inflow from financing activities of ¥349,875,818.59 in Q1 2025, compared to a net outflow of ¥14,291,603.98 in Q1 2024[24] - The company experienced a net cash outflow from investing activities of ¥127,467,665.17 in Q1 2025, compared to a net outflow of ¥84,384,252.57 in Q1 2024[24] Research and Development - R&D expenses totaled ¥13,091,217.53, representing 12.06% of revenue, a decrease of 0.69 percentage points from the previous year[5] - Research and development expenses increased to ¥13,091,217.53 in Q1 2025, up 18.3% from ¥11,063,960.91 in Q1 2024[18]

胜科纳米（苏州）股份有限公司 2025 年第一次临时股东大会 会议资料 2025年4月28日 胜科纳米（苏州）股份有限公司 2025 年第一次临时股东大会 证券代码：688757 证券简称：胜科纳米 胜科纳米（苏州）股份有限公司 2025年第一次临时股东大会 | | | | 2025 | 年第一次临时股东大会会议须知 | 1 | | --- | --- | --- | | 2025 | 年第一次临时股东大会会议议程 | 3 | | 2025 | 年第一次临时股东大会会议议案 | 5 | 胜科纳米（苏州）股份有限公司 2025 年第一次临时股东大会 胜科纳米（苏州）股份有限公司 2025 年第一次临时股东大会会议须知 为维护广大投资者的合法权益，保障股东在本次股东大会期间依法行使权利， 根据《中华人民共和国公司法》、中国证券监督管理委员会《上市公司股东大会 规则》等法律法规和胜科纳米（苏州）股份有限公司（以下简称"公司"）《股 东大会议事规则》等有关规定，特制定本会议须知： 一、公司负责本次股东大会的议程安排和会务工作，为确认出席大会的股东 或其代理人或其他出席者的出席资格，会议工作人员将对出席会议者的身份进行 ...